Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2021
Filter by date:
Showing 974 press releases before 2021
-
BRILINTA Demonstrated Greater Efficacy Over Clopidogrel in the Most Urgent Clinical Setting: Patients with ST-Segment Elevation Myocardial Infarction and Planned Percutaneous Coronary Intervention (PCI)
-
Discovery Research Leader Leaves AstraZeneca
-
AstraZeneca PLC Third Quarter & Nine Months Results 2009
-
AstraZeneca withdraws regulatory submissions for Zactima (vandetanib) in combination with chemotherapy for advanced NSCLC
-
Patients Taking VIMOVO(TM) Showed Decrease in incidence of NSAID Associated Ulcers
-
AstraZeneca Submits Marketing Authorisation Application to European Union for VIMOVO™
-
US Food and Drug Administration Approves CRESTOR for Use in Pediatric Patients with Heterozygous Familial Hypercholesterolemia
-
Study Finds That ONGLYZA (saxagliptin) When Added to Metformin was Non-Inferior to Januvia (sitagliptin) When Added to Metformin in Reducing Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus
-
ONGLYZA (saxagliptin) Receives Marketing Authorisation in Europe for the Treatment of Type 2 Diabetes
-
Seroquel XR and Seroquel Approved in Europe for Prevention of Recurrence of Bipolar Disorder
Latest articles and press releases
All of our latest press releases and articles are available to explore